IRVINE, CA, Developer of the novel Hydrus Microstent device designed to lower eye pressure for glaucoma patients, announced today that it closed a $25 million Series C financing. Read More
SAN FRANCISCO, CA, Leader in developing best-in-class therapies to address the unmet needs of migraine sufferers, today announced the closing of a $12 million Series A financing. Read More
INDIANAPOLIS, IN, Internet of Things (IoT) provider connecting all Energy Things, today announced $10 million in financing from new investors. Read More